Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3773107011 | Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3773108018 | Carbidopa and levodopa only product in oromucosal dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4513961000052116 | läkemedel som endast innehåller karbidopa och levodopa, läkemedelsform för munhåla | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Is a | Carbidopa- and levodopa-containing product in oromucosal dose form | true | Inferred relationship | Some | ||
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | räkning av bas i aktiv ingrediens | 2 (qualifier value) | false | Inferred relationship | Some | ||
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Has manufactured dose form | Oromucosal dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Is a | Product containing only carbidopa and levodopa (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Has active ingredient | Carbidopa | true | Inferred relationship | Some | 2 | |
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Has active ingredient | Levodopa (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Plays role | Antiparkinson therapeutic role | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | True | Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Inferred relationship | Some | |
| Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug) | Is a | True | Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Inferred relationship | Some | |
| Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet | Is a | True | Product containing only carbidopa and levodopa in oromucosal dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR